Spots Global Cancer Trial Database for fluconazole
Every month we try and update this database with for fluconazole cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma | NCT02532192 | Lymphoma | Belinostat Rituximab Cisplatin Cytarabine Dexamethasone Ciprofloxacin Fluconazole | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies | NCT04551963 | B-cell Malignan... | Zanubrutinib Fluconazole Diltiazem Voriconazole Clarithromycin | 18 Years - | BeiGene | |
| A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections | NCT00002277 | Mycoses HIV Infections | Fluconazole Amphotericin B | 13 Years - | NIH AIDS Clinical Trials Information Service | |
| Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients | NCT03028103 | Diffuse Large B... Primary Mediast... Mantle Cell Lym... Advanced Solid ... Marginal Zone L... | Tazemetostat Fluconazole Omeprazole Repaglinide | 18 Years - | Ipsen | |
| Candida Associated Cytokines in Oral Leukoplakia | NCT04712929 | Oral Leukoplaki... | Fluconazole | 18 Years - 100 Years | All India Institute of Medical Sciences, New Delhi | |
| Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients | NCT03028103 | Diffuse Large B... Primary Mediast... Mantle Cell Lym... Advanced Solid ... Marginal Zone L... | Tazemetostat Fluconazole Omeprazole Repaglinide | 18 Years - | Ipsen | |
| Candida Associated Cytokines in Oral Leukoplakia | NCT04712929 | Oral Leukoplaki... | Fluconazole | 18 Years - 100 Years | All India Institute of Medical Sciences, New Delhi | |
| Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors | NCT02122770 | Advanced Solid ... | MLN4924 Fluconazole Itraconazole Docetaxel Carboplatin Paclitaxel | 18 Years - | Takeda | |
| Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant | NCT01503515 | Fungal Infectio... Hematopoietic a... | Caspofungin Ace... Fluconazole Laboratory Biom... Voriconazole | 3 Months - 20 Years | Children's Oncology Group | |
| A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors | NCT02222922 | Neoplasms | PF-06647020 Q3W fluconazole PF-06647020 Q2W PF-06647020 com... | 18 Years - | Pfizer | |
| Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors | NCT02122770 | Advanced Solid ... | MLN4924 Fluconazole Itraconazole Docetaxel Carboplatin Paclitaxel | 18 Years - | Takeda | |
| Blood and Marrow Transplant Clinical Research Network | NCT00023530 | Bone Marrow Tra... Blood Disease Hematopoietic S... Leukemia Multiple Myelom... Myelodysplastic... Graft vs Host D... | fluconazole voriconazole bone marrow tra... thalidomide dexamethasone | 2 Years - | National Heart, Lung, and Blood Institute (NHLBI) | |
| A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors | NCT02222922 | Neoplasms | PF-06647020 Q3W fluconazole PF-06647020 Q2W PF-06647020 com... | 18 Years - | Pfizer | |
| Candida Associated Cytokines in Oral Leukoplakia | NCT04712929 | Oral Leukoplaki... | Fluconazole | 18 Years - 100 Years | All India Institute of Medical Sciences, New Delhi | |
| Blood and Marrow Transplant Clinical Research Network | NCT00023530 | Bone Marrow Tra... Blood Disease Hematopoietic S... Leukemia Multiple Myelom... Myelodysplastic... Graft vs Host D... | fluconazole voriconazole bone marrow tra... thalidomide dexamethasone | 2 Years - | National Heart, Lung, and Blood Institute (NHLBI) | |
| To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers | NCT02093728 | Solid Tumours | selumetinib itraconazole itraconazole selumetinib selumetinib fluconazole fluconazole selumetinib | 18 Years - 45 Years | AstraZeneca | |
| Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies | NCT04551963 | B-cell Malignan... | Zanubrutinib Fluconazole Diltiazem Voriconazole Clarithromycin | 18 Years - | BeiGene | |
| Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia | NCT01307579 | Acute Myeloid L... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Alkylating Agen... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Fungal Infectio... Myeloid Neoplas... Neutropenia Recurrent Adult... Recurrent Child... Secondary Acute... Untreated Adult... Untreated Child... | Caspofungin Ace... Fluconazole Laboratory Biom... | 3 Months - 30 Years | Children's Oncology Group | |
| Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors | NCT02122770 | Advanced Solid ... | MLN4924 Fluconazole Itraconazole Docetaxel Carboplatin Paclitaxel | 18 Years - | Takeda | |
| A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors | NCT02222922 | Neoplasms | PF-06647020 Q3W fluconazole PF-06647020 Q2W PF-06647020 com... | 18 Years - | Pfizer | |
| PTX3-targeted Antifungal Prophylaxis | NCT03828773 | Candidiasis Fungal Infectio... Acute Myeloid L... Genetic Predisp... Aspergillosis | Posaconazole Fluconazole | 18 Years - | Centre Hospitalier Universitaire Vaudois |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
